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Résumé en français du travail de thèse (article, enjeu, contexte de la recherche, conclusions et perspectives) 
Lors de mon activité clinique en 2017 aux Hôpitaux universitaires Sud de Marseille j’effectue, sous la supervision du 
Professeur Argenson, un suivi rétrospectif non randomisé de patients souffrant de dysplasie développementale de 
hanche (DDH) de haut grade (Crowe III ou IV) ayant été traités avec prothèse totale de hanche (PTH) en un temps 
opératoire avec tige fémorale non cimentée faite sur mesure. Il n’existe pas de publication relatant des résultats à long 
terme pour des implants fémoraux sur mesure utilisant une seule technique opératoire pour ce type de malades. Peu de 
centres disposent de données suffisantes, vu le nombre restreint de patients Crowe III/IV. La prise en charge dans les 
pays développés se faisant plus tôt que par le passé. 
Les options pour l’implantation d’une PTH en cas de DDH haut grade incluent l’ostéotomie sous-trochantérienne avec 
raccourcissement fémoral (risque de mauvaise consolidation, risque d’inégalité de longueur des membres inférieurs 
important), le haut positionnement du centre de la hanche (risque de descellement augmenté), la chirurgie en deux 
temps avec abaissement progressif utilisant un fixateur externe avant PTH (risque d’infection accru, séjour hospitalier 
prolongé). Les résultats à long terme sont très hétéroclites dans la littérature. Pour des raisons biomécaniques et 
biologiques le centre de rotation original devrait être conservé et par conséquent la réduction ouverte pour restaurer la 
longueur du membre inférieure sans lésion neurologique est difficile. Nous avons décrit les résultats à long terme d’une 
technique en un temps opératoire par un abord de Watson-Jones sans ostéotomie sous-trochantérienne utilisant une 
tige sur mesure non cimentée et fréquemment associée à des ténotomies séquentielles pour l’abaissement du fémur et 
à une ostéotomie du grand trochanter quand l’antéversion fémorale est excessive. Pas de libération des muscles 
abducteurs, du tenseur du fascia lata ou du nerf sciatique. Une autogreffe de la tête fémorale est utilisée si la couverture 
de l’acétabulum est insuffisante. Les composants prothétiques employés sont une cupule en titane non cimentée 
recouverte d’hydroxyapatite toujours placée dans l’acétabulum anatomique (Hilock Rev, Symbios), un insert UHWP 
avec rebord, une tête céramique, une tige sur mesure en titane non cimentée recouverte d’hydroxyapatite (Symbios). 
Collecte-analyse des données cliniques/radiologiques et soumission des travaux à Journal of Arthroplasty le 15 
décembre 2017 (5-year impact factor 3.146, SJR 2.373). 
98 PTH ont été effectuées à Marseille en utilisant cette technique, dont 26 hanches sont des DDH de haut grade avec 
un suivi moyen sur 16 ans. Cela concerne 23 patients avec une moyenne d’âge de 45 ans, une taille moyenne de 160 
cm et un poids moyen de 69 Kg. L’allongement moyen désiré selon planification et tenant compte des déformations 
de la colonne, des genoux et des pieds est de 32 mm (3-80). L’antéversion fémorale moyenne est de 21 degrés (8-46). 
Le Student’s t-test est utilisé pour les variables continues et une analyse de Kaplan-Meier pour la survie des implants 
(tige, cupule, polyéthylène) en regard des motifs de révision (descellement aseptique, défaillance mécanique ou usure). 
Le Harris Hip Score moyen augmente significativement de 49 à 86 points. La satisfaction des patients avec un score 
subjectif d’auto-évaluation est pour 65% excellent et pour 35% bien. 17 patients marchent sans canne. 20 hanches ne 
présentent aucune douleur. 10 hanches ne présentent aucune boiterie, 10 une discrète, 5 une modérée et 1 une boiterie 
sévère. Il n’y a aucune corrélation entre le fait de marcher avec des cannes, la boiterie ou le score subjectif d’auto-
évaluation. La différence moyenne de longueur des membres inférieurs est de 36 mm (3-80) préopératoire et de 7 mm 
(0-17) postopératoire. 
Parmi les complications: une lésion transitoire du nerf sciatique et une du nerf fémoral avec récupération complète à 
18 et 11 mois, deux luxations récidivantes traitées l’une par repositionnement du polyéthylène et l’autre par révision 
de la cupule pour meilleur repositionnement, une non-union du grand trochanter qui a nécessité une ORIF. 5 autres 
révisions ont été effectuées : une cupule a été changée pour descellement aseptique à 95 mois, une tige a été changée 
suite à une fracture Vancouver B2, deux tiges ont été changées pour descellement aseptique à 111 et 161 mois, un 
polyéthylène a été remplacé à 132 mois pour usure symptomatique. Pas d’infection, pas de lésion vasculaire, pas de 
fracture intraopératoire. On constate radiologiquement lors du dernier contrôle une ligne radiolucente non progressive 
acétabulaire dans la zone 1 sur une hanche. Une ostéolyse fémorale asymptomatique sur deux hanches dans la zone 1. 
Des ossifications hétérotopiques grade 1 sur une hanche. Pas de critère pour une mauvaise ostéointégration de la tige, 
une instabilité de la cupule ou une mauvaise ostéointégration de la greffe acétabulaire. L’analyse de survie à 15 ans 
concernant le descellement aseptique de la tige est de 87,5% et de la cupule de 96,1%. 
La combinaison d’un bon ancrage intramédullaire et d’une bonne adaptation extramédullaire concernant l’offsetet 
l’antéversion fournie par la tige sur mesure permet d’éviter des procédures chirurgicales supplémentaires et un 
programme de réhabilitation accéléré. Le surcoût de l’implant fémoral sur mesure est compensé par un court séjour 
hospitalier et par l’absence d’un ancillaire. Malgré le petit nombre de patients et le design rétrospectif de l’étude, la 
fonction clinique, le peu de complications neurologiques et la survie à long terme signalées dans cette série sont 
encourageantes pour ce groupe de patients ayant développé une coxarthrose secondaire. Au vu de la rareté des cas il 
paraît difficile de pouvoir effectuer une étude prospective randomisée. 
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Background: Options for total hip arthroplasty (THA) in high dislocated hips include subtrochanteric
osteotomy (STO), high hip center positioning, and 2-stage surgery with progressive lowering using an
external ﬁxator before THA. We described the long-term results of 1-stage THA performed without STO,
using a cementless customized stem associated if necessary with sequential tenotomies and/or greater
trochanteric osteotomy.
Methods: Ninety-eight consecutive THA without STO were performed using this technique. Of those 98
hips, 26 hips with high dislocation (12 class III and 14 class IV according to the Crowe classiﬁcation) were
evaluated at an average follow-up of 16 (10-22) years.
Results: At the time of last follow-up, the mean Harris Hip Score was 86 points (37-100). The mean leg-
length discrepancy was 7 ± 5 mm (0-17). Two transient (7.7%) nerve palsies (1 sciatic and 1 femoral) were
notiﬁed. A revision was required for 6 hips (23.1%). Kaplan-Meier survivorship analysis at 15 years
regarding aseptic loosening of the femoral component was 87.5% (95% conﬁdence interval, 76.5-99.1).
During the same period, acetabular implant survivorship free from revision for aseptic loosening was
96.1% (95% conﬁdence interval, 92.7-99.9).
Conclusion: The combination of intramedullary ﬁt and extramedullary adaptation for offset and ante-
version provided by the custom stem can avoid additional procedures associated to THA in high
developmental dysplasia of the hip. The clinical function and long-term survival reported in this series is
encouraging for THA performed in case of high hip dislocation.
© 2018 Elsevier Inc. All rights reserved.Total hip arthroplasty (THA) for neglected developmental
dysplasia of the hip (DDH) is a technically demanding procedure for
arthroplasty surgeons [1e3]. The placement of the acetabular
component in the true acetabulum is considered to be the ideal
choice for biomechanical and biological reasons [4e12]. It can, thus,
be challenging to reduce the hip joint and achieve leg-lengthclosed potential or pertinent
ent, either direct or indirect,
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tment of Orthopedic Surgery
erite Hospital, 270 Boulevardrestoration while avoiding neurologic traction injury [13,14].
Therefore, to overcome contractures and to reduce the hip without
stretching the sciatic nerve, femoral shortening has been intro-
duced by Paavilainen et al [15] and Eskelinen et al [16] as an adjunct
to THA. Several authors have reported long-term results of THA for
high DDH performed using shortening osteotomy [16e21]. To avoid
the complications related to osteotomy, recent reports documented
2-stage progressive femoral lowering followed by a cementless
THA (Yoon et al [22], Binazzi [23]). However, only few papers have
documented the long-term results of isolated cementless THA in
such etiology (Crowe III and IV) [24,25] and none using isolated
custom stems. In the review by Tsiampas et al [26], the long-term
series mentioned in the article with custom-made femoral im-
plants was not only focused on high DDH but also combined
femoral shortening osteotomy was used intermittently. The
O.F. Hitz et al. / The Journal of Arthroplasty 33 (2018) 2197e22022198purpose of the present retrospective study is to report the clinical
and radiographic minimum 10-year outcome of THA for Crowe III
and IV DDH using a customized stem without shortening osteot-
omy, associated with sequential tenotomies and/or greater
trochanter osteotomy if needed.
Methods
Patients
Ninety-eight one-stage THAs for late DDH (82 patients) were
performed at a single institution. The Crowe classiﬁcation has been
used to assess the magnitude of subluxation of the femoral head
[14]. This classiﬁcation includes 4 types: I (<50% subluxation), II
(50e75% subluxation), III (75e100% subluxation), and IV (100%
subluxation). Of those 98 hips, 26 hips (23 patients) were classiﬁed
according to the Crowe classiﬁcation as type III (n ¼ 12) and IV
(n ¼ 14) and were followed up from 1990 to 2013. There were 18
females and 5 males. The mean age at the time of the procedure
was 45 ± 12.3 (17-63) years. The average height was 160 ± 6.2 (150-
170) cm, and the average weight was 69 ± 12.8 (46-118) kg. There
were 13 left hips and 13 right hips. Thirteen hips (50%) had a
previous surgery on the considered hip, including 6 shelf arthro-
plasties, 5 intertrochanteric osteotomies, 1 open reduction, and 1
Chiari pelvic osteotomy. The mean follow-up was 16 (10-22) years.
Preoperative Planning
The preoperative planning included anteroposterior (AP) pelvic
view, AP and lateral view of the considered hip, full frontal view of
the lower limbs, positioning the patient supine, and a computed
tomography (CT) scan. A 3-dimensional reconstruction of the in-
ternal and external geometry of the femur was created based on
digital imaging and communications in medicine format images
obtained from a CT scan that included the acetabular roof proxi-
mally to the posterior femoral bicondylar axis distally [27,28]. In
presence of structural changes in the lumbosacral spine, mala-
lignment of the ipsilateral knee and/or equinus foot, a lateral view
of the lower limbs was obtained. The mean preoperative leg-length
discrepancy (LLD) was 36 ± 26 (3-80) mm. According to the Crowe
classiﬁcation, the mean preoperative LLD was 27 ± 20 (3 to 60) mm
and 45 ± 29 (5-80) mm, respectively, in type III and IV (P ¼ .003).
Taking into account the spine, knee, and/or foot abnormalities, the
desired lengthening was 32 ± 26 (3-80) mm, with 24 ± 18 (3 to 58)
mm and 45 ± 29 (5 to 80) mm for Crowe type III and IV, respectively
(P ¼ .004). The mean preoperative anteversion of the proximal fe-
mur was 21 ± 13 (8-46).
Surgical Technique
All the procedures were performed under general anesthesia by
a senior surgeon using the anterolateral Watson-Jones approach
in supine position without a traction table. Greater trochanteric
osteotomy (GTO) was performed in 6 hips (23%) with lateral repo-
sitioning when excessive femoral anteversion was present to relo-
cate the abductormuscles action line and avoid a posterior position.
Sequential tenotomieswere performed if needed for lowering of the
femur including adductor or iliopsoas tenotomy (22 hips, 85%). Once
the psoas insertion was released, the femoral head-neck resection
could be performed at the level of the lesser trochanter to ensure a
complete capsule detachment. No abductor or fascia lata muscles
release, intertrochanteric shortening or rotational femoral osteot-
omy was performed, and no external ﬁxator was used. No sciatic
nerve tension assessment or release was performed. In all cases, an
hemispheric press-ﬁt uncemented titanium alloy, hydroxyapatite(HA)-coated acetabular component (Hilock Rev, Symbios, Yverdon,
Switzerland) was implanted in the true acetabulum with a hook
placed in the obturator foramen and 2 screws in the acetabular roof.
Autogenous femoral head grafts were used to provide additional
superolateral acetabular coverage in 7 hips (27%), 3 in Crowe III (3 of
12, 25%), and 4 in Crowe IV (4 of 14, 29%). A conventional ultra-high-
weight polyethylene 20 elevated liner was used in associationwith
a ceramic head. The average diameter of the cupwas 46 (36-56)mm.
A 3-dimensional cementless custom HA-coated titanium femoral
component (Symbios, Yverdon, Switzerland) has been used for all
patients ﬁtting the intramedullary proximal femoral anatomy and
accommodating the 3-dimensional offset of the femoral neck to
obtain the correct hip center [3,27,29]. GTO, when performed,
was stabilized with 3 cerclages with the lower limb in abduction.
After skin closure and wound management, a pillow was used to
position the lower limb in abduction and ﬂexion, when an intra-
operative contracture was present after THA reduction. Neurologic
and vascular complications were immediately assessed in the
recovery room.
Postoperative Management
All patients were mobilized on the ﬁrst day after THA, sitting on
bed. On the second day, they were asked to stand up, helped by a
physiotherapist, and on the third day, they were allowed to walk
with partial weight bearing protected by 2 crutches. The 2 crutches
were used for 6 weeks in case of greater trochanter osteotomy,
without active abduction workout, and for 3 weeks, when no
greater trochanter osteotomy was performed, and a single crutch
on the opposite side was required for 3 additional weeks. No brace
was used. Exercises focused on passive and then active recupera-
tion of ROM. Routine thromboprophylaxis was used with low-
molecular-weight heparin preoperatively and postoperatively for
3 weeks.
Clinical and Radiographic Evaluations
Clinical evaluation was performed using the Harris Hip Score
(HHS) [30] preoperatively and postoperatively. A 5-scale satisfac-
tion score was used (patients rated their hip status as excellent,
good, fair, poor, and disappointing). The presence of intraoperative
or postoperative complications including infection, nerve palsy,
dislocations, or loosening was recorded. Standard AP and lateral
radiographs performed at the most recent follow-up examination
were compared with the ﬁrst postoperative radiographs. The
assessment criteria were the osteointegration of the femoral
component according to Engh and Bobyn [31], radiolucent lines and
periprosthetic osteolysis in the femur according to the 7 zones from
the study byGruen et al [32], the presence of radiolucent lines at the
acetabular-bone interface according to DeLee and Charnley [33], the
stability of the acetabular component as described by Zicat et al [34]
in each of the 3 zones from the study by DeLee and Charnley [33],
the acetabular graft osteointegration according to Conn et al [35],
the grade of heterotopic ossiﬁcation according to Brooker et al [36],
and the fusion at the site of greater trochanter repositioning.
Statistical Methods
Data are presented as mean values with ranges. The Student's t
test was used for comparisons of continuous variables. P value < .05
was signiﬁcant. Kaplan-Meier survivorship analysis [37] was per-
formed with 2 end points: (1) revision for any reason and (2)
revision for aseptic loosening, mechanical failure, or wear. Statis-
tical analysis was performed using SPSS software (IBM, Armonk,
New York).
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The mean HHS of the 23 patients (26 hips) increased signiﬁ-
cantly from preoperative (49 ± 22 points) to the most recent
follow-up examination (86 ± 13 points; P < .0001). At the last
follow-up, the mean HHS pain subscore was 41 ± 5 points, with 20
hips (77%) showing no pain. Seventeen patients (74%) walked
without any aid. Ten hips (38.5%) did not show any limping, 10
(38.5%) had a slight, 5 (19.2%) a moderate, and 1 (3.8%) a severe
limping. Using the subjective satisfaction self-evaluation, 15
patients (65%) rated their results as excellent and 8 (35%) as good.
No correlation was found between patients using a walking aid,
limping, and their satisfaction evaluation.
Themean LLDwas 7± 5 (0-17)mm. Therewere 2 (7.7%) transient
nerve palsies (1 sciatic and 1 femoral). The sciatic nerve palsy was
recorded in a 38-year-old female with a bilateral Crowe IV DDH that
had a previous shelf arthroplasty only on the right side. She under-
went 2 sequential THAs with planed lengthening of 48 mm on the
right side and 53 mm on the left side. The nerve palsy was recorded
on the right side and resolved completely at 18months. TheHHSwas
87 at the ﬁnal follow-up, and the satisfactory evaluationwas rated as
good. The secondwas a femoral palsywhich resolved in 11months. It
was a 51-year-old female with a right Crowe IV DDH and a length-
ening to be realized of 29 mm. She did not have previous surgery on
the considered hip. The HHS was 88 at the ﬁnal follow-up, and the
satisfactory evaluation was rated as good.
Two patients (8.7%) had recurrent hip dislocations. The ﬁrst one
was a 63-year-old woman with a left Crowe III DDH. She was
treated by repositioning of the elevated liner and did not have any
other subsequent dislocation. The ﬁnal HHS was 77 and her satis-
faction evaluationwas rated as good. The second onewas a 17-year-
old female who underwent a THA for a Crowe III DDHwho required
an early cup revision for better positioning. The ﬁnal HHS was 97
points, and the satisfaction evaluation was rated as good. One hip
(3.8%) had a symptomatic greater trochanter nonunion which
required an open reduction and internal ﬁxation. The ﬁnal HHSwas
91, but a crutch was required to walk. All the acetabular compo-
nents were located in the true acetabulum without detectable
migration (Fig. 1).
The radiographic analysis at the last follow-up showed a
nonprogressive radiolucent line around the acetabular component
in zone 1 in 1 hip (3.8%) according to DeLee and Charnley [33]. AnFig. 1. Crowe IV DDH with greater trochantasymptomatic femoral osteolysis was present in 2 hips (7.7%) in
zone 1 according to Gruen [32]. Heterotopic ossiﬁcations were
observed in 1 hip (3.8%) and were classiﬁed as grade 1 according to
Brooker et al [36]. No pronounced resorptionwas noted around the
femoral components according to Engh and Bobyn [31]. All
acetabular components were considered as stable according to
Zicat et al [34]. All cases with acetabular graft showed a good
osteointegration according to Conn et al [35].
A revision was needed in 6 hips (23.1%). In addition to the early
cup revision for instability mentioned previously, 1 cup was revised
for aseptic loosening at 95 months. In 3 hips (11.5%), the stem was
revised: 1 for a Vancouver B2 fracture (acute trauma) and 2 (7.7%)
for aseptic loosening at 111 and 161 months. In 1 hip (3.8%), the
liner was changed for symptomatic wear at 132 months.
Kaplan-Meier survivorship analysis at 15 years of the femoral
component considering revision for aseptic loosening as the end
point was 87.5% (95% conﬁdence interval, 76.5-99.1) (Fig. 2). For the
acetabular implant considering aseptic loosening as the end point,
survivorship was 96.1% (95% conﬁdence interval, 92.7-99.9) (Fig. 3).
Survivorship analysis at 15 years for both implants was 72.6% (95%
conﬁdence interval, 45.3-99.9) regarding any reason as the end
point. The number of hips at risk for revision was 10 at 15 years.
Discussion
Several techniques have been described to address end-stage
osteoarthritis in Crowe type III or IV DDH using THA. The key
aspect for achieving long-term stability of the acetabular compo-
nent relies on excellent coverage of the cup and restoration of the
center of rotation of the hip into an anatomical position [7]. Linde
et al [38] reported that at a mean follow-up of 9 years, the place-
ment of the acetabular component in the true acetabulum pro-
duced a much lower loosening rate than placement above the true
acetabulum (13% and 42%, respectively). Pagnano et al [8] found
that positioning of the cup proximal to the true acetabular region
was associated with substantial increase in loosening. These ob-
servations indicate that the acetabular component should be
positioned in the true acetabular region in patients with high DDH.
The present study, using a 1-stage surgical technique without
subtrochanteric osteotomy (STO), has shown that all the acetabular
components were located in the true acetabulum without detect-
ablemigration and a 96.1% cup survival at 15 years of follow-up. Theer osteotomy and 38-mm lengthening.
Fig. 2. Kaplan-Meier curve showing 87.5% survivorship free from stem revision
regarding aseptic loosening at 15 years.
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provides anatomical ﬁt and 3D neck correction for anticipating
surgical difﬁculties found in this etiology related to proximal
femoral anatomy. The clinical results are encouraging in a young
and active population while exhibiting satisfactory lower limb
equalization and limited neurological complications.
Anatomic socket placement canmake hip reduction difﬁcult and
reduction may require considerable limb lengthening associated
with increased risk of neurological injury [13,14]. Therefore,
femoral shortening has been proposed to facilitate reduction and
protect the sciatic and femoral nerves. It is a 1-stage technique,
using the femoral component for intramedullary stabilization that
also allows for correction of a severe anteversion of the femoral
neck. However, the procedure remains challenging as in-
congruences may appear between the proximal and distal canal
diameters after shortening osteotomy leading to difﬁculties for
achieving a secure ﬁxation; these difﬁculties might increase the
risk of delayed union or nonunion of the osteotomy
[18,27,29,39e41]. While Ollivier et al [19] mentioned for Crowe IV
patients a nonunion rate at femoral shortening osteotomy site of
7%, Mutlu et al [42] reported in Crowe III and IV patients either
18.6% nonunion or 20.9% delayed union depending on the type of
cementless stem used. Kawai et al [43] using cemented stems
mentioned an average time to union of the osteotomy site of 4.9
(3-8) months and that full weight bearing was allowed after 12-16
weeks. Using cementless stems, weight bearing is usually carefully
increased depending on the consolidation of the osteotomy siteFig. 3. Kaplan-Meier curve showing 96.1% survivorship free from cup revision
regarding aseptic loosening at 15 years.starting at 6 weeks and fully completed at 12 weeks according to
several authors [16,17,44e47]. In the present series without STO,
patients were allowed to walk with partial weight bearing at day 3
with the help of 2 crutches and full weight bearing was normally
applied after 3 weeks if a GTO was performed.
Additional complications related to the procedure have been
described as nerve palsies [39e41,48,49], intraoperative femoral
fracture [13,18,29], and dislocation [13,18,40,41,49]. Mu et al [50]
using cementless Zweymüller THA with STO in 71 Crowe IV pa-
tients mentioned 1 case of complete and 7 cases of transient nerve
palsies, 1 cup loosening, 4 polyethylene wear and 1 cup breakage, 1
dislocation, and 20 intraoperative fractures. In the present series
using custom stems, we did not ﬁnd any intraoperative fracture,
probably in relation with the adaptation between the stem and the
proximal modiﬁed anatomy often found in such etiology. However,
the major concern described with the shortening osteotomy tech-
nique remains the residual postoperative LLD especially if the DDH
is unilateral [13,40,49]. The average 7 (0-17) mm postoperative
mean LLD reported in the present series using a custom femoral
stem is close to the 6 (0-20) mm reported by Ollivier et al [19] but
compares favorably with the other series associating a STO and
reporting average LLD from 12 to 14 mm with maximum values
ranging from 0 to 60 mm [16,17,45e47].
Long-term results of THA for high DDH with shortening
osteotomy showed heterogeneous results. Eskelinen et al [16] fol-
lowed up 64 hips and reported a 10-year survival rate of 98.4% for
the stem and 94.9% for the porous-coated cup, but 8 of the 9
threaded cups were revised. Hartoﬁlakidis and Karachalios [9]
followed up 84 hips with cemented or uncemented cups and
cemented stems and reported an overall 15-year survival rate of
82.5% for the stem and 86.1% for the cup. Ollivier et al [19] reviewed
28 hips (24 cementless, 4 cementless modular stem and cementless
cup) with a mean follow-up of 10 years and reported a 10-year
survivorship of the components free of revision of 82%. Reikeras
et al [17] followed up 64 hips with uncemented components
(straight conical stem full HA and HA or titanium porous-coated
cup) at a mean follow-up of 13 years and reported a 15-year sur-
vival for any reason of 75% for the cup and 100% for the stem.
However, 1 stem subsided after 8 months and was replaced.
Regarding outcomes of THA without shortening osteotomy for
Crowe III or IV hips, Kerboull et al [48] using a transtrochanteric
approach and cemented components in 83 hips reported a survival
rate of 78% at 16 years with revision for any reason as the end point.
Numair et al [51] reported higher rates of acetabular revision in
completely dislocated hips with cemented components, as
compared with dysplastic hips. Chougle et al [52] reported a cup
survival rate for aseptic loosening in Crowe IV hips of 60.9% at 10
years. Kawai et al [53] reported a survival rate after trans-
trochanteric approach and cemented THA of 96.3% at 10 years with
any revision surgery as the end point. Using cementless THAs
without shortening osteotomy for Crowe III or IV hips, Imbuldeniya
et al [24] showed for 25 hips, a survival with revision for any reason
of 81% at 15 years with 57% of the patients who had a revision of the
acetabular component secondary to polyethylene wear. Proximal
osteolysis in zone 1 or 7 around the femoral stemwas found in 10 of
the 25 hips, all implanted with modular S-ROM stems. Lee et al [25]
reported in 27 hips with GTO and various types of cups and stems at
a mean follow-up of 15.1 years, a mean LLD of 10 mm, 2 transient
peroneal nerve palsies and 2 permanent neurologic deﬁcits
(1 femoral, 1 sciatic), 3 intraoperative fractures, and a survival rate
for aseptic loosening at 15 years of 90.9% for stem and 52.3% for cup.
The use of custom-made stem has been described mostly for
low-grade DDH patients [54e56] or with short-term follow-up
[57] or were indicated for various femoral deformity etiologies
[58]. Benum and Aamodt [55] using occasional subtrochanteric
O.F. Hitz et al. / The Journal of Arthroplasty 33 (2018) 2197e2202 2201osteotomies for lengthening reported no case of stem aseptic
loosening at 10-year follow-up. Akbar et al [58] reported cup
loosening of 5 cups in 72 hips with any progressive femoral
osteolysis after a mean follow-up of 14 years.
Although some authors have reported that limb lengthening
should be limited to 4 cm [59], Kerboull et al [48] reported that limb
lengthening until 7 cm was possible. In our study using an ante-
rolateral approach with sequential tenotomies, it was always
possible to reduce the hip into the true acetabulum without the
need for a femoral shortening, including the 19 hips (73%) that had
a lengthening superior to 4 cm. Two (7.7%) nerve palsies were
documented and both recovered. Another option is to perform a
2-stage progressive femoral lengthening followed by a cementless
THA. Binazzi [23] documented the clinical radiographic results of 11
patients (12 hips) who were operated with a 2-stage technique at a
mean follow-up of 11 ± 5 years with no neurovascular damage or a
need for femoral internal ﬁxation and complete limb symmetry.
However, 1 hip (8.3%) had a remaining postoperative LLD of 1.8 cm.
A potential increased risk of infection remains, owing to the use of
an external ﬁxator, and the hospital stay was increased by 2 weeks,
corresponding to the time needed for lengthening before the sec-
ond stage. Yoon et al [22] described a 2-stage operation planned in
6 irreducible hips when expected lengthening of the affected limb
after THA was superior to 2.5 cm or when ﬂexion contracture was
superior to 30. Surgical hip release with abductor slide, tensor
fascia lata, sartorius muscle, iliopsoas tendon, and rectus femoris
release was performed through 2 skin incisions during the ﬁrst
stage. Gradual skeletal traction was thus applied to the operated
limb for 2 weeks before performing the THA. However, 5 of 6 hips
(83%) were difﬁcult to reduce requiring a subtrochanteric short-
ening osteotomy to prevent neurologic traction injuries. In the
lengthening technique described in the present series, tenotomies
of either the adductors or psoas were performed sequentially to
reduce the risk of neurological complications. In our experience, a
complete muscle function for active ﬂexion and abduction was
achieved 6 months after surgery. Eggli et al [60] mentioned
that most nerve lesions after leg lengthening occurred by direct or
indirect trauma to the nerve during surgery. The incidence of
permanent nerve lesion seemed higher without STO in the study by
Sonohata et al [61], but nerve palsies are also present with STO
techniques. A recent study by Li et al [62] compared 2 groups of
Crowe IV patients who underwent cementless THA, one with (20
hips) and one without (22 hips) subtrochanteric shortening
osteotomy. The group without femoral shortening osteotomy had a
lower postoperative mean LLD and a lower number of patients who
developed a limp, more transient femoral nerve palsy (3, all
reversible after 6 months), and more knee valgus deformity due to
tight soft tissue/iliotibial tract (mostly reversible at the end of
follow-up after stretching). The group with osteotomy had one
intraoperative fracture and one delayed union at osteotomy site. No
sciatic nerve palsy or dislocation was recorded in both groups.
The mean postoperative HHS in the present series using a
custom monoblock cementless stem was 86, and the survival at 15
years regarding aseptic loosening was 87.5% for the stem and 96.1%
for the cup, all of them implanted in the true acetabulum in a series
of Crowe III and IV dislocated hips. The 3D evaluation of the
proximal femur anatomy in high DDH [1,27] has shown several
important modiﬁcations the orthopedic surgeon has to face at the
time of THA in such patients compared to primary osteoarthritis
[28,29]. The use of custom stem allows fast weight bearing and
quick rehabilitation program. Nowadays, the routine use of pre-
operative CT planning is largely accepted to better assess the 3D
anatomy in complex degenerative or traumatic cases to anticipate
difﬁculties during surgery like in THA for high DDH. The 20%
additional cost of the custom stem, when compared to off-the-shelfanatomical implant, is hopefully compensated by the reduced
length of stay related to immediate weight bearing and the early
recovery. This extra cost is also reduced because there is no need for
ancillary tools. The 15-year survival, with stable clinical improve-
ment, is encouraging in a group of young patients with a mean age
of 45 years, implanted with THA for osteoarthritis secondary to
high DDH.
This study has some limitations, including the limited number of
patients and its retrospective design; however, THA for highDDHdo
represent an uncommon and challenging situation for which large
prospective studies with a long follow-up are not available. Despite
these limitations, the present series is the longest series to date
investigating the outcome of cementless THA without shortening
osteotomy using a custom stem combined with sequential tenoto-
mies in patients with a high hip dislocation secondary to DDH.References
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